A complex MLL rearrangement identified five years after initial MDS diagnosis results in out-of-frame fusions without progression to acute leukemia

Meyer, 2009, New insights to the MLL recombinome of acute leukemias, Leukemia, 23, 1490, 10.1038/leu.2009.33 Pui, 2003, Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements, Leukemia, 17, 700, 10.1038/sj.leu.2402883 Balgobind, 2009, Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study, Blood, 114, 2489, 10.1182/blood-2009-04-215152 Lavau, 1997, Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL, EMBO J, 16, 4226, 10.1093/emboj/16.14.4226 So, 2003, Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias, Cancer Cell, 4, 99, 10.1016/S1535-6108(03)00188-0 Rowley, 1997, All patients with the t(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders, Blood, 90, 535 Bain, 1998, Myelodysplastic syndromes associated with 11q23 abnormalities. European 11q23 Workshop participants, Leukemia, 12, 834, 10.1038/sj.leu.2401020 Pappa, 2004, Absence of MLL gene rearrangement in de novo myelodysplastic syndromes (MDS), Ann Hematol, 83, 170, 10.1007/s00277-003-0818-7 Andersen, 2001, Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents, Genes Chromosomes Cancer, 31, 33, 10.1002/gcc.1115 Look, 2005, Molecular pathogenesis of MDS, Hematology Am Soc Hematol Educ Program, 156, 10.1182/asheducation-2005.1.156 Bacher, 2009, The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes, Cancer, 115, 4524, 10.1002/cncr.24501 Taki, 1997, The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene, Blood, 89, 3945, 10.1182/blood.V89.11.3945 Satake, 1997, Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation, Genes Chromosomes Cancer, 20, 60, 10.1002/(SICI)1098-2264(199709)20:1<60::AID-GCC9>3.0.CO;2-7 Zhang, 2004, Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16), Genes Chromosomes Cancer, 41, 257, 10.1002/gcc.20077 Robinson, 2008, Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome, Blood, 111, 3802, 10.1182/blood-2007-07-096065 Nemoto, 2007, Identification of a novel fusion gene MLL-MAML2 in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23), Genes Chromosomes Cancer, 46, 813, 10.1002/gcc.20467 Snijder, 2008, Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia, Cancer Genet Cytogenet, 180, 149, 10.1016/j.cancergencyto.2007.10.003 Kreuziger, 2007, An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome, Leuk Res, 31, 1145, 10.1016/j.leukres.2006.12.006 Meyer, 2005, Diagnostic tool for the identification of MLL rearrangements including unknown partner genes, Proc Natl Acad Sci U S A, 102, 449, 10.1073/pnas.0406994102 Meyer, 2006, The MLL recombinome of acute leukemias, Leukemia, 20, 777, 10.1038/sj.leu.2404150 Corral, 1996, An MLL-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes, Cell, 85, 853, 10.1016/S0092-8674(00)81269-6 Mori, 2010, Persistent detection of a novel MLL-SACM1L rearrangement in the absence of leukemia, Leuk Res, 34, 1398, 10.1016/j.leukres.2010.05.001